Background The National AIDS Control Program (NACP)-IV has been endorsed by our hospital since 2013. Tuberculosis (TB) and Sexually Transmitted Infections (STI) increase the risk of HIV acquisition and vice versa, therefore, NACP- IV, Revised National Tuberculosis Control Program (RNTCP) and National STD control programs were linked in India for better patient outcome.

Methods This is a 3-year retrospective study conducted at Integrated Counseling and Testing Centre (ICTC) of our tertiary care hospital from January 2016 to December 2018. HIV seropositivity among ICTC attendees; HIV-TB and HIV-STI co-infection rates were tested and analyzed as per the National guidelines.

Results A total of 44738 ICTC attendees were tested for HIV, of which 1347 were positive (approximately 3%). Seropositivity was found to be highest in the reproductive age group (25–49 years). A decline in HIV seropositivity rate was seen, though the number of clients increased by approximately 20% each year. HIV-TB co-infection rate was found to be 0.18% in 2016, 0.15% in 2017 and 0.17% in 2018 among patients attending DOTS (Directly Observed Treatment Short-Course) centre. HIV positivity among patients referred from STI clinic showed a declining trend from 2.5% in 2016 to 1.35% in 2017 and 0.6% in 2018.

Conclusion It is pertinent to point out the role of counseling, both pretest and posttest, in the National AIDS Control Program, India. ICTC provides comprehensive services, for identification and documentation of HIV related co-infections including TB and STIs. Very few studies have been conducted in our country analysing the outcome of linkage between National programs (NACP-IV, RNTCP and National STD control programs). Our centre took the initiative to study this linkage to aid in better patient outcome.

Disclosure No significant relationships.